shington , june 29 , 2016 /prnewswire/ -- at vice president biden 's national cancer moonshot summit today , the u.s. department of veterans affairs and ibm watson health ( nyse : ibm ) announced a public-private partnership to help doctors expand and scale access to precision medicine over the next two years for 10,000 american veterans with cancer . newline_char va oncologists michael kelley ( left ) and neil spector review a watson for genomics dna analysis report . newline_char on wednesday at vp biden 's national cancer moonshot summit , va and ibm launched a public-private partnership to help doctors expand and scale access to precision medicine over the next two years for 10,000 american veterans  newline_char ibm 's watson for genomics technology is expected to help in the department 's precision oncology program by providing information to help physicians identify precision treatment options for almost 30 times more patients than could be previously served . story_separator_special_tag  story_separator_special_tag some 3.5 % of the nation ’ s care patients are being treated at va facilities , the largest group of cancer patients within a single health care group . newline_char the partnership will bring ibm ’ s watson for genomics technology into the u.s. department of veterans affair ’ s hospitals and doctors ’ offices so that more former soldiers can access the best in precision medicine in the battle against cancer . story_separator_special_tag the addition of watson 's brain power , which can understand questions in natural language and not just the computer language of ones and zeros , could significantly accelerate cancer treatment . newline_char here 's a question ibm supercomputer watson never got to ask on " jeopardy " : what is a cure for cancer ? newline_char ibm unveiled watson for genomics , specifically designed for this task , at the national cancer moonshot summit on wednesday .
